Summit Therapeutics Inc. Common Stock (SMMT) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for SMMT. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 209 institutions reported holding SMMT, with 65.5 million shares worth $1.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 15,202,075 | $257M | DECREASED |
| BlackRock | 10,363,750 | $175M | INCREASED |
| FMR | 8,136,745 | $138M | DECREASED |
| State Street | 6,093,474 | $103M | DECREASED |
| Geode Capital Management | 3,489,224 | $59M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Bhaskar Anand (Chief Accounting Officer) | AWARD | 100,000 | 2026-10-08 |
Full institutional holdings, insider history, and congressional trades for Summit Therapeutics Inc. Common Stock on SentiSense.